Crossject nomme Dan
Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord
June 12, 2024 01:30 ET | CROSSJECT
Dr Chiche mettra à profit sa vaste expérience en matière de développement de médicaments aux États-Unis et à l'international et de valorisation de produits médicaux ;Renforcera l'équipe dirigeante...
Crossject appoints D
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
June 12, 2024 01:30 ET | CROSSJECT
Brings extensive experience in drug development in the U.S and internationally and in maximizing value of medical productsReinforces leadership team and expands presence in North AmericaSupports...
Clinical ink Appoint
Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
June 10, 2024 08:00 ET | Clinical Ink
Winston Salem, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, announced the appointment of Dr. Nicholas Alp as Chief Medical Officer and EVP, Medical...
Lantheus_Logo.png
Lantheus Announces Executive Appointments to Accelerate Innovation
May 15, 2024 16:30 ET | Lantheus Holdings, Inc.
Jeffrey S. Humphrey, MD appointed Chief Medical Officer;Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”)...
ITM Announcement_Portrait Photo Dr. Danielle Meyrick
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
May 07, 2024 05:00 ET | ITM Isotope Technologies Munich SE
Leveraging profound knowledge in radiopharmaceutical drug development and commercial planning, Dr. Meyrick will lead the medical team in further developing and delivering on ITM's pipeline...
DSC01168
Ocean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical Officer
April 17, 2024 07:48 ET | Ocean Drive Plastic Surgery
Dr. Alan Durkin (Ocean Drive Plastic Surgery) has been appointed Chief Medical Officer of innovative aesthetic and wellness franchise company, VIO Med Spa.
AVEO_LG Chem_Logo(Hi-Resolution).jpg
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 28, 2024 15:22 ET | AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned...
AVEO_LG Chem_Logo(Hi-Resolution).jpg
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 25, 2024 08:10 ET | AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...
Osmol-logo-blue-small-margins2.png
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
March 04, 2024 08:00 ET | Osmol Therapeutics
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
January 30, 2024 09:15 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...